Raymond James Financial Services Advisors, Inc. Ani Pharmaceuticals Inc Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 07, 2019	SELL	$64.7 - $85.39 $174,301 - $230,040	-2,694 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$67.77 - $82.2 $17,959 - $21,783	-265 Reduced 8.96%	2,694 $221,000
Q1 2019 May 06, 2019	BUY	$45.83 - $70.54 $135,610 - $208,727	2,959 New	2,959 $209,000
Q3 2018 Nov 14, 2018	SELL	$52.95 - $71.34 $207,193 - $279,153	-3,913 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$56.38 - $68.08 $220,614 - $266,397	3,913 New	3,913 $261,000
Q4 2017 Feb 09, 2018	SELL	$53.3 - $74.56 $534,225 - $747,314	-10,023 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$43.46 - $52.49 $23,033 - $27,819	530 Added 5.58%	10,023 $526,000
Q2 2017 Aug 15, 2017	BUY	N/A	9,493	9,493 $444,000

Others Institutions Holding ANIP

# of Institutions

212

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.03B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account